EyePoint, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
EyePoint, Inc. (EYPT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 1.28% for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2016-11-08
- EyePoint, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2016-09-30 was 1.28%.
- EyePoint, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2016 was 1.97%, a 1.50% decline from fiscal 2015.
- EyePoint, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2015 was 2.00%, a 0.50% increase from fiscal 2014.
- EyePoint, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2014 was 1.99%, a 103.06% increase from fiscal 2013.
- EyePoint, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2013 was 0.98%, a 51.49% decline from fiscal 2012.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month |
|---|---|---|---|---|
| 2016-09-30 | 1.28% 10-Q · filed 2016-11-08 | |||
| 2016-06-30 | 1.97% 10-K · filed 2016-09-13 | |||
| 2016-03-31 | 1.97% 10-Q · filed 2016-05-06 | |||
| 2015-12-31 | 1.97% 10-Q · filed 2016-02-09 | |||
| 2015-06-30 | 2.00% 10-K · filed 2016-09-13 | |||
| 2015-03-31 | 2.00% 10-Q · filed 2015-05-08 | |||
| 2014-12-31 | 2.00% 10-Q · filed 2015-02-06 | |||
| 2014-06-30 | 1.99% 10-K · filed 2016-09-13 | |||
| 2014-03-31 | 1.99% 10-Q · filed 2014-05-14 | |||
| 2013-12-31 | 1.99% 10-Q · filed 2014-02-12 | |||
| 2013-06-30 | 0.98% 10-K · filed 2015-09-10 | |||
| 2012-06-30 | 2.02% 10-K · filed 2014-09-11 | |||
| 2011-06-30 | 2.35% 10-K · filed 2013-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |